{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:22:05Z","timestamp":1768893725157,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-01066-z","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T17:06:25Z","timestamp":1765559185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A tissue-penetrably engineered deoxyribonuclease 1 to prevent nasal polyp formation in chronic rhinosinusitis"],"prefix":"10.1186","volume":"27","author":[{"given":"Su-Bin","family":"Kwak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roza","family":"Khalmuratova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Woo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Wan","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"1066_CR1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1177\/0194599814559898","volume":"152","author":"RM Rosenfeld","year":"2015","unstructured":"Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, Brook I, Ashok Kumar K, Kramper M, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015;152:S1\u201339.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1066_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4193\/Rhin17.255","volume":"57","author":"A Khan","year":"2019","unstructured":"Khan A, Vandeplas G, Huynh TMT, Joish VN, Mannent L, Tomassen P, et al. The global allergy and asthma European network (GALEN rhinosinusitis cohort: a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps. Rhinology. 2019;57:32\u201342.","journal-title":"Rhinology"},{"key":"1066_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-020-00218-1","volume":"6","author":"C Bachert","year":"2020","unstructured":"Bachert C, Marple B, Schlosser RJ, Hopkins C, Schleimer RP, Lambrecht BN, et al. Adult chronic rhinosinusitis. Nat Rev Dis Primers. 2020;6:86.","journal-title":"Nat Rev Dis Primers"},{"key":"1066_CR4","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1002\/lary.21969","volume":"121","author":"SC Payne","year":"2011","unstructured":"Payne SC, Early SB, Huyett P, Han JK, Borish L, Steinke JW. Evidence for distinct histologic profile of nasal polyps with and without eosinophilia. Laryngoscope. 2011;121:2262\u201367.","journal-title":"Laryngoscope"},{"key":"1066_CR5","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.jaci.2009.05.017","volume":"124","author":"PP Cao","year":"2009","unstructured":"Cao PP, Li HB, Wang BF, Wang SB, You XJ, Cui YH, et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immun. 2009;124:478\u201384.","journal-title":"J Allergy Clin Immun"},{"key":"1066_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.23838\/pfm.2022.00072","volume":"6","author":"G Ryu","year":"2022","unstructured":"Ryu G, Kim HY, Jung YG, Hong SD. Endotypes of Asian chronic rhinosinusitis with nasal polyps a narrative review. Precis Future Med. 2022;6:170\u201376.","journal-title":"Precis Future Med"},{"key":"1066_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/all.12064","volume":"68","author":"LL Shi","year":"2013","unstructured":"Shi LL, Xiong P, Zhang L, Cao PP, Liao B, Lu X, et al. Features of airway remodeling in different types of Chinese chronic rhinosinusitis are associated with inflammation patterns. Allergy. 2013;68:101\u201309.","journal-title":"Allergy"},{"key":"1066_CR8","doi-asserted-by":"crossref","unstructured":"Zhang C, Zhang QQ, Chen JN, Li H, Cheng FY, Wang YZ, et al. Neutrophils in nasal polyps exhibit transcriptional adaptation and proinflammatory roles that depend on local polyp milieu. JCI Insight. 2024;9:e184739.","DOI":"10.1172\/jci.insight.184739"},{"key":"1066_CR9","doi-asserted-by":"crossref","unstructured":"Lim S, Khalmuratova R, Lee YY, Kim YS, Lee MY, Lee NK, et al. Neutrophil extracellular traps promoteDnp631basal cell hyperplasia in chronic rhinosinusitis. J Allergy Clin Immun. 2024;153:705\u201317.","DOI":"10.1016\/j.jaci.2023.11.016"},{"key":"1066_CR10","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303:1532\u201335.","journal-title":"Science"},{"key":"1066_CR11","doi-asserted-by":"publisher","first-page":"107602","DOI":"10.1016\/j.celrep.2020.107602","volume":"31","author":"TD Tsourouktsoglou","year":"2020","unstructured":"Tsourouktsoglou TD, Warnatsch A, Ioannou M, Hoving D, Wang Q, Papayannopoulos V. Histones, DNA, and citrullination promote neutrophil extracellular trap inflammation by regulating the localization and activation of TLR4. Cell Rep. 2020;31:107602.","journal-title":"Cell Rep"},{"key":"1066_CR12","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1002\/art.39296","volume":"67","author":"H Wang","year":"2015","unstructured":"Wang H, Li T, Chen S, Gu Y, Ye S. Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-of-concept trial of metformin. Arthritis Rheumatol. 2015;67:3190\u2013200.","journal-title":"Arthritis Rheumatol"},{"key":"1066_CR13","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/nm.3887","volume":"21","author":"SL Wong","year":"2015","unstructured":"Wong SL, Demers M, Martinod K, Gallant M, Wang YM, Goldfine AB, et al. Diabetes primes neutrophils to undergo NETosis, which impairs wound healing. Nat Med. 2015;21:815.","journal-title":"Nat Med"},{"key":"1066_CR14","doi-asserted-by":"publisher","first-page":"120389","DOI":"10.1016\/j.biomaterials.2020.120389","volume":"267","author":"YY Lee","year":"2021","unstructured":"Lee YY, Park HH, Park W, Kim H, Jang JG, Hong KS, et al. Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm. Biomaterials. 2021;267:120389.","journal-title":"Biomaterials"},{"key":"1066_CR15","doi-asserted-by":"publisher","first-page":"100689","DOI":"10.1016\/j.nmni.2020.100689","volume":"35","author":"AP Earhart","year":"2020","unstructured":"Earhart AP, Holliday ZM, Hofmann HV, Schrum AG. Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome. New Microbes New Infect. 2020;35:100689.","journal-title":"New Microbes New Infect"},{"key":"1066_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.biopha.2017.06.009","volume":"93","author":"L Laukov\u00e1","year":"2017","unstructured":"Laukov\u00e1 L, Konecn\u00e1 B, B\u00e1b\u00edckov\u00e1 J, Wagnerov\u00e1 A, Meliskov\u00e1 V, Vlkov\u00e1 B, et al. Exogenous deoxyribonuclease has a protective effect in a mouse model of sepsis. Biomed Pharmacother. 2017;93:8\u201316.","journal-title":"Biomed Pharmacother"},{"key":"1066_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1046\/j.1365-2249.1996.d01-839.x","volume":"106","author":"M Macanovic","year":"1996","unstructured":"Macanovic M, Sinicropi D, Shak S, Baughman S, Thiru S, Lachmann PJ. The treatment of systemic lupus erythematosus (SLE) in NZB\/W F1 hybrid mice; studies with recombinant murine DNase and with dexamethasone. Clin Exp Immunol. 1996;106:243\u201352.","journal-title":"Clin Exp Immunol"},{"key":"1066_CR18","doi-asserted-by":"publisher","first-page":"5668","DOI":"10.1016\/S0021-9258(19)70681-4","volume":"255","author":"SE Hitchcock","year":"1980","unstructured":"Hitchcock SE. Actin deoxyroboncuclease I interaction. Depolymerization and nucleotide exchange. J Biol Chem. 1980;255:5668\u201373.","journal-title":"J Biol Chem"},{"key":"1066_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/347037a0","volume":"347","author":"W Kabsch","year":"1990","unstructured":"Kabsch W, Mannherz HG, Suck D, Pai EF, Holmes KC. Atomic structure of the actin:DNase I complex. Nature. 1990;347:37\u201344.","journal-title":"Nature"},{"key":"1066_CR20","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/jps.22054","volume":"99","author":"DS Pisal","year":"2010","unstructured":"Pisal DS, Kosloski MP, Balu-Iyer SV. Delivery of therapeutic proteins. J Pharm Sci. 2010;99:2557\u201375.","journal-title":"J Pharm Sci"},{"key":"1066_CR21","doi-asserted-by":"publisher","first-page":"122526","DOI":"10.1016\/j.lfs.2024.122526","volume":"342","author":"SB Kwak","year":"2024","unstructured":"Kwak SB, Kim SJ, Kang YJ, Lee WW, Huh J, Park JW. Development of a rectally administrable Dnase1 to treat septic shock by targeting NETs. Life Sci. 2024;342:122526.","journal-title":"Life Sci"},{"key":"1066_CR22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2018;18:134\u201347.","journal-title":"Nat Rev Immunol"},{"key":"1066_CR23","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.autrev.2017.09.012","volume":"16","author":"KH Lee","year":"2017","unstructured":"Lee KH, Kronbichler A, Park DD, Park Y, Moon H, Kim H, et al. Neutrophil extracellular traps (NETs) in autoimmune diseases: a comprehensive review. Autoimmun Rev. 2017;16:1160\u201373.","journal-title":"Autoimmun Rev"},{"key":"1066_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/ACI.0000000000000868","volume":"23","author":"T Delemarre","year":"2023","unstructured":"Delemarre T, Bachert C. Neutrophilic inflammation in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol. 2023;23:14\u201321.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"1066_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jaci.2020.08.036","volume":"147","author":"T Delemarre","year":"2021","unstructured":"Delemarre T, Holtappels G, De Ruyck N, Zhang N, Nauwynck H, Bachert C, et al. A substantial neutrophilic inflammation as regular part of severe type 2 chronic rhinosinusitis with nasal polyps. J Allergy Clin Immun. 2021;147:179.","journal-title":"J Allergy Clin Immun"},{"key":"1066_CR26","doi-asserted-by":"publisher","first-page":"e255","DOI":"10.2500\/ajra.2011.25.3727","volume":"25","author":"DW Kim","year":"2011","unstructured":"Kim DW, Khalmuratova R, Hur DG, Jeon SY, Kim SW, Shin HW, et al. Staphylococcus aureus enterotoxin B contributes to induction of nasal polypoid lesions in an allergic rhinosinusitis murine model. Am J Rhinol Allergy. 2011;25:e255\u2013261.","journal-title":"Am J Rhinol Allergy"},{"key":"1066_CR27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.4168\/aair.2020.12.3.507","volume":"12","author":"G Ryu","year":"2020","unstructured":"Ryu G, Bae JS, Kim JH, Kim EH, Lyu L, Chung YJ, et al. Role of IL-17A in chronic rhinosinusitis with nasal polyp. Allergy Asthma Immunol Res. 2020;12:507\u201322.","journal-title":"Allergy Asthma Immunol Res"},{"key":"1066_CR28","doi-asserted-by":"crossref","unstructured":"Howard EL, Goens MM, Susta L, Patel A, Wootton SK. Anti-drug antibody response to therapeutic antibodies and potential mitigation strategies. Biomedicines. 2025;13;299.","DOI":"10.3390\/biomedicines13020299"},{"key":"1066_CR29","doi-asserted-by":"crossref","unstructured":"Stroppel L, Schultz-Fademrecht T, Cebulla M, Blech M, Marhofer RJ, Selzer PM, et al. Antimicrobial preservatives for protein and peptide formulations: an overview. Pharmaceutics. 2023;15:563.","DOI":"10.3390\/pharmaceutics15020563"},{"key":"1066_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/JAA.S10839","volume":"3","author":"R Anolik","year":"2010","unstructured":"Anolik R. Fluticasone furoate nasal spray: profile of an enhanced-affinity corticosteroid in treatment of seasonal allergic rhinitis. J Asthma Allergy. 2010;3:87\u201399.","journal-title":"J Asthma Allergy"},{"key":"1066_CR31","doi-asserted-by":"publisher","first-page":"Np621","DOI":"10.1177\/01455613211026425","volume":"102","author":"DA Brake","year":"2023","unstructured":"Brake DA, Hamilton GS, Bansberg SF. Nasal septal perforation due to desmopressin nasal spray use. ENT-Ear Nose Throat. 2023;102:Np621\u201324.","journal-title":"ENT-Ear Nose Throat"},{"key":"1066_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2045-7022-2-9","volume":"2","author":"PW Hellings","year":"2012","unstructured":"Hellings PW, Dobbels F, Denhaerynck K, Piessens M, Ceuppens JL, De Geest S. Explorative study on patient\u2019s perceived knowledge level, expectations, preferences and fear of side effects for treatment for allergic rhinitis. Clin Transl Allergy. 2012;2:9.","journal-title":"Clin Transl Allergy"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01066-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-01066-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01066-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T17:40:09Z","timestamp":1768844409000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-025-01066-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1066"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-01066-z","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Blood sampling and experimental procedures to obtain human neutrophils were conducted following approval from the Institutional Review Board (IRB) of Seoul National University Hospital (C-2208-143-1353). All experimental protocols for animal experiments were complied with the governmental and international guidelines. The protocols were approved by the Institutional Animal Care and Use Committee of Seoul National University (SNU-240403-2-3). Since we here used a commercially available mouse strain (BALB\/c) purchased from Orient Bio Inc. (Seongnam, Korea), any informed consent from the owner was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This study does not include any individual person\u2019s data in any form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}